Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly

Clinical trial NCT06090955 · UNKNOWN

Trial details

NCT number: NCT06090955
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Delirium, Postoperative

Start date: 2023-10-25
Primary completion: 2024-11-30
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.